Tissue- and age-dependent expression of RNA-binding proteins that













































Throughout the lifetime of an organism, gene 
expression programs change dynamically.  The specific 
subsets of proteins expressed at each point in time allow 
cells to carry out long-term functions, such as those 
needed during development and differentiation, and 
short-term adaptive changes, including responses to 
acute environmental or hormonal stimuli.  The gene ex-
























































































developmental stages are strongly regulated at the 
transcriptional level.  Transcription factors (TFs) such 
as FOXO (forkhead box), PPAR (peroxisome prolifera-
tor-activated receptor)γ, p53, C/EBP (CCAAT/enhann- 
cer-binding protein), as well as by chromatin re-
modeling factors such as MRG and HDACs have been 
implicated in aging and age-related processes [1-6]. 
 
However, gene expression patterns are also potently re-
gulated by RNA-binding proteins (RBPs), which control 
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splicing, and mRNA cytoplasmic export, turnover, 
storage, and translation [7-10].  Unlike TFs, much less 
is known about the role of RBPs in aging and age-
related events.  A subset of RBPs which function 
as translation and turnover regulatory (TTR) RBPs is of 
particular interest, since numerous genes implicated in 
age-related processes encode mRNAs that are labile 
and/or subject to translational control [11].  Examples 
of age-related proteins whose mRNAs are targets of 
TTR-RBPs include p16
INK4, p21
CIP1, cyclins (D1, E, A, 
B1, and H), cdk1 (cyclin-dependent kinase 1), CAK 
(cdk-activating kinase), amyloid precursor protein 
(APP), endothelin-1, fibronectin, interleukin (IL)-1, 
Cu,Zn- and Mn-superoxide dismutase (SOD), growth 
arrest- and DNA damage-inducible (GADD)45, 
plasminogen activator inhibitor (PAI)-1 and PAI-2, 
collagenase, granulocyte macrophage-colony-
stimulating factor (GM-CSF) and M-CSF, p53, bcl-2, 
p33
ING1, c-fos, catalase, E2F-1,-2, DP-1, elastin, 
thymidine kinase, insulin growth factor (IGF)-II, 
dihydrofolate reductase, PCNA, ribonucleotide 
reductase, and histones (reviewed in [11]).  Here, we 
use arrays of human tissue biopsies to study the tissue 
distribution of four major TTR-RBPs as a function of 
age:  HuR (human antigen R), AUF1 (AU-binding 
factor 1, also called heterogenous ribonucleoprotein D 
or hnRNP D), TIA (T-cell intracellular antigen)-1, and 
TTP (tristetraprolin).   
 
HuR is the ubiquitously expressed member of the 
embryonic lethal abnormal vision (ELAV)/Hu protein 
family, which also comprises the primarily neuronal 
proteins HuB, HuC, and HuD [12].  Through its RNA-
recognition motifs (RRMs), HuR binds to numerous 
mRNAs bearing AU- and U-rich sequences and 
stabilizes and/or modulates their translation [12-14].   
Many HuR target mRNAs encode proteins important 
for cell growth, proliferation, and survival, as well as 
for the immune and stress responses [11, 12, 15-17].   
Examples include mRNAs that encode cyclins (A, B1, 
E, D1), c-fos, c-myc, vascular endothelial growth factor 
(VEGF), hypoxia-inducible factor-1α (HIF-1α), 
prothymosin-α, cyclooxygenase (COX)-2, tumor 
necrosis factor (TNF)-α, and several interleukins 
(reviewed in [11, 12]). 
 
AUF1 comprises four proteins that arise from 
alternative splicing (p37, p40, p42, p45) and shuttle 
between the nucleus and the cytoplasm [18, 19].  AUF1 
has also been implicated in several distinct post-
transcriptional processes.  Originally found to promote 
mRNA decay, as revealed in studies using a variety of 
cell systems [20-23], in some instances AUF1 has been 
shown to enhance mRNA stability and to promote 
translation [21, 24-26].  All of the AUF1 isoforms 
contain two RRMs through which they bind to a select 
group of mRNAs, including many mRNAs that encode 
stress-response, immune, and proliferative proteins such 
as p21, cyclin D1, myc, fos, GM-CSF, TNF-α, IL-3, 
parathyroid hormone (PTH), and GADD45α [21-24, 27, 
28].   
 
TIA-1 and the TIA-1-related protein (TIAR) are 
believed to play general roles as translational repressors 
in response to environmental stress agents (heat, 
oxidants, hyperosmolarity, etc.) [29-33].  Such 
damaging factors trigger the aggregation of TIA-1 into 
discrete cytoplasmic foci called stress granules (SGs), 
wherein mRNAs are thought to be stored transiently and 
subsequently sorted into the translation and degradation 
machineries.  Many TIA-1/TIAR target mRNAs, often 
C-rich or U-rich [33, 34], are translationally repressed 
when they are associated with TIA-1/TIAR and become 
translated upon dissociation from TIA-1 [27, 33, 35].  
TIA-1 regulates the translation of mRNAs encoding 
TNF-α, COX-2, and several other transcripts bearing a 
TIA-1 motif [29, 31, 36].  
 
The product of the ZFP-36 gene, TTP is also known as 
TIS11, Nup475, and GOS24.  TTP binds mRNAs 
through two tandem CCCH zinc finger motifs and 
promotes their decay [37].  TTP target mRNAs 
typically contain the AU-rich sequence 
UUAUUUAUU, although TTP also binds to tandem 
repeats of the shorter sequence UUAU [38, 39].  TTP is 
induced as an immediate-early response gene in 
response to inflammatory mediators and growth factors 
in many cell types, including T cells, macrophages, and 
fibroblasts [40-43].  By destabilizing one of its target 
transcripts, TNF-α mRNA, TTP reduced inflammation 
[40].  TTP also induced the decay of other mRNAs, 
such as those encoding GM-CSF, COX-2, IL-3, IL-10, 
and interferon-γ [44-48].  
 
We previously reported that cultured human diploid 
fibroblasts (HDFs) undergoing replicative senescence 
showed reduced levels of HuR, which contributed to the 
diminished expression of cyclin A, cyclin B1, and c-fos 
in senescent HDFs [49], and also showed reduced 
AUF1 levels, which contributed to elevating p16 
abundance, a senescence marker in this cell system [50].  
Fibroblasts explanted from donors of different ages, 
then briefly expanded in culture, also showed a 
moderate reduction in HuR levels as the age of the 
donor increased [49].  There is agreement that senescent 
HDFs recapitulate some features of cells from the 
elderly and there is broad support for the notion that 
cellular senescence constitutes a tumor suppressive 
mechanism, particularly in young and middle-aged 
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senescence and aging or age-related processes are 
considerably weaker.   
 
A systematic study of TTR-RBPs in human tissues has 
not been performed to-date.  Yet many age-related 
genes are encoded by mRNAs which are labile and/or 
subject to translational regulation.  Therefore it was 
important to investigate the expression of TTR-RBPs, 
particularly HuR, AUF1, TIA-1, and TTP, in a panel of 
human tissues spanning different ages.  We quantified 
both the percentages of TTR-RBP-positive cells and 
their relative intensity as a function of individual donor 
age.  This analysis provided a wealth of information;  
salient among it was the finding that HuR, AUF1, and 
TIA-1 remained highly expressed in many aging tissues, 
particularly in gastrointestinal (GI) and reproductive 
organs, despite their reduced abundance in replicative 
senescent HDFs.  It was also interesting to discover that 
TTP expression pattern was opposite to that of other 
TTR-RBPs, increasing with replicative senescence and 
decreasing in many tissues with advancing age.  These 
findings reveal an important discordance between TTR-
RBP levels during replicative senescence and those 
present during in vivo aging, and provide a valuable 
framework of tissue- and age-dependent TTR-RBP 
expression for future in vivo analyses.  Furthermore, 
they suggest that HuR, AUF1, and TIA-1 likely play 





HuR, AUF1, and TIA-1 levels decrease and TTP 
levels increase during replicative senescence 
 
To investigate the relative changes in TTR-RBP levels 
occurring with replicative senescence and with increas-
ing age, we began by assessing TTR-RBP abundance in 
HDFs.  Early-passage, proliferating (‘young’) WI-38 
HDFs were cultured until they ceased cell division and 
became senescent, as previously reported [51].  At the 
indicated population doublings (pdls), protein lysates 
were prepared and the levels of HuR, AUF1, TIA-1, and 
TTP were detected by Western blot analysis.  As shown 
in Figure 1, HuR, AUF1, and TIA-1 were most 
abundant in early-passage HDFs (pdl 21), declining 
thereafter, as previously reported for HuR and AUF1 
[49, 50].  The levels of AUF1 and TIA-1 declined 
markedly by pdls 33 and 43, becoming virtually 
undetectable by pdl 52, when cells were senescent, 
while the decline in HuR levels was slower and less 
pronounced.  Unexpectedly, the expression pattern of 
TTP was just the opposite, displaying extremely low 
levels in early-passage cells and increasing dramatically 
as WI-38 HDFs reached senescence.  The levels of 



























population  doublings  (pdls),  until  they  reached  senescence  at
~pdl  52.  The  abundance  of  TTR‐RBPs  HuR,  AUF1  (all  four










HuR levels remain elevated in numerous tissues with 
advancing age 
 
In order to study the tissue- and age-dependent 
expression patterns of TTR-RBPs, we obtained tissue 
arrays which contained a panel of healthy tissue 
biopsies from human donors of different ages (fetal 
through adult; Array II, BioChain Institute;  FDA 35, 
Pantomics, Inc.).  The tissue arrays were probed with an 
anti-HuR antibody in order to visualize HuR signals in 
the different tissues; the slides were then scanned and 
the digital images were analyzed as explained in the 
Methods section.  For the analysis, the donors’ ages 
were grouped as follows:  fetal (F), young (Y, birth to 
30 years of age), middle-aged (M, 30 to 60 years of 
age), or old (O, over 60 years of age).  The exact ages 
and tissue types of the biopsies analyzed in both arrays 
are listed (supplementary Table S1).  The signals of 
each spot on the array were measured in two ways:  by 
counting the percentage area of positive cells (% HuR 
positive) and by measuring the intensity of the signals 
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calculated from the digitized images using a color 
deconvolution algorithm to identify diaminobenzidine 
(DAB, “brown”) positivity in defined regions of 
interest (ROI) [52].  The data were tabulated showing 

















































parenthesis, and the average percentage values with 
the color scheme shown;  in some cases, a tissue in a 
given age group was not available in either of the 
arrays studied (n.a.).  Negative immunohistochemis-
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virtually all tissues and age groups (Table 1, left 
columns), but were very low in neuronal and muscle 
tissues.  The numbers of HuR-positive cells remained 
relatively unchanged with increasing age in most tissues 
examined, increasing with age only in the lung and in 
the gastrointestinal (GI) tract (small intestine, colon, 
rectum).  When HuR intensities were compared (Table 
1, right columns), there was little loss in HuR 
abundance with advancing age in most tissues 
examined, declining only in the nervous system.  Most 
tissues showed little change in HuR levels across age 
groups (e.g., skeletal muscle, skin, and reproductive and 
urinary systems), although an increase was observed 









































nals were seen throughout age groups in the GI, 
reproductive, and urinary systems. 
 
Representative photographs from the tissue array are 
shown (Figure 2).  Samples from the GI tract (stomach, 
small intestine, colon) and the immune system (spleen, 
thymus) were selected, as the levels and age-dependent 
changes in these tissues were particularly interesting for 
all TTR-RBPs examined.  In summary, HuR was 
ubiquitously expressed in a broad range of human 
tissues and showed strong intensity despite advancing 
age.  These results contrasted with the loss of HuR 
expression seen in senescent HDFs ([49], Figure 1), and 
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abundant, increasing with age in the immune system  
 
The analysis of AUF1 in tissue arrays was performed as 
described above for HuR.  Interestingly, the relative 
percentages of AUF1-expressing cells throughout the age 
groups, as well as the relative intensities of AUF1 signals 
were rather similar to those seen for HuR (compare Table 
2 with Table 1);  the tight correlation between AUF1 and 
HuR signals was quantified (supplementary Figure S2).  
A similar correlation between AUF1 and HuR expression 
levels was noted by Lu and Schneider, who compared 










































AUF1-positive cells were detected in all tissues 
examined, but were low in muscle, and high in the GI 
and immune systems.  AUF1 abundance increased with 
age in the immune system and was overall high in the 
lung, GI tract, and urinary and reproductive systems.   
Representative photographs of AUF1 expression in the 
GI and immune tissues are shown in Figure 3.  As seen 
with HuR, there was discordance between the steep 
decline in AUF1 levels in senescent HDFs and the 
markedly elevated AUF1 levels seen in tissues from 
elderly donors (Table 2).  These findings support the 
notion that AUF1 also plays a functional role in the 
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groups   
  
While TIA-1 also displayed a ubiquitous distribution, 
TIA-1-positive cells showed a moderate decline in some 
tissues of the GI and muscle systems (Table 3, left 
columns).  Unlike HuR and AUF1, the relative intensity 
of TIA-1 in several tissues declined with advancing age, 
as seen in the endocrine, urinary, and muscle systems.  
Despite a moderate decline in TIA-1 signals in the GI 
tract, its levels remained relatively high here and were 
also elevated in all age groups in the respiratory, immune, 
and reproductive systems (Table 3, right columns).   
Sample photographs of TIA-1 signals in immune and GI 
specimens are shown in Figure 4.  Once again, TIA-1 
followed a time-dependent pattern of expression in 
tissues that was largely opposite to what was seen in 
cultured WI-38 HDFs advancing towards senescence: 
highly expressed in vivo (Table 3, Figure 4), progressive-
ly lower until almost undetectable in vitro (Figure 1).   
These observations suggest that TIA-1 may also be im-

































General decline in TTP-expressing cells and TTP 
levels with advancing age 
 
Like TIA-1, the numbers of TTP-expressing cells were 
highest in the fetal (F) group, generally decreasing in 
older groups (Table 4, left columns).  Exceptions to this 
pattern were the GI and endocrine systems, where TTP-
positive cell numbers remained constant across age 
groups, and the reproductive tissues, where TTP-
positive cells increased with advancing age.  TTP inten-
sities also generally declined across tissue types when 
examining progressively older donors (Table 4, right 
columns).  Representative micrographs from the GI and 
immune systems are shown (Figure 5).  The dis-
agreement between replicative senescence and in vivo 
aging was also seen with TTP, as senescent cells 
expressed increasingly higher TTP, while advancing 
age progressively lowered the number of TTP-
expressing cells and TTP abundance per cell.  Although 
TTP levels can be induced by a variety of stimuli, the 
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Our results reveal an interesting discordance between 
the levels of four TTR-RBPs in human fibroblasts 
undergoing replicative senescence and their levels in 
tissues from individuals of increasing age.  In WI-38 
cells, senescence potently lowered HuR, AUF1, and 
TIA-1 levels, while it increased TTP abundance (Figure 
1).  Accordingly, we hypothesized that the levels of 
HuR, AUF1, and TIA-1 might also decline with aging, 
while TTP levels might increase.  Using a robust 
method to quantify immunohistochemical signals 
present in different tissue types and age groups, we 
discovered that in vivo, these TTR-RBPs were 
expressed in precisely the opposite pattern: HuR, 
AUF1, and TIA-1 remained highly abundant with 
advancing age, in some cases even increasing their 
expression, while TTP levels generally decreased in the 
aged groups (compare Figure 1 with Tables 1-4).  This 



































of HDFs as an in vitro model of aging and the broad 
agreement that senescent cells arise in normal tissues 
with aging in vivo, as discussed elsewhere [54].   
However, since senescent cells are terminally arrested 
and may be cleared by immune cells, perhaps they are 
underrepresented in the tissues examined here.   
Additionally, key differences exist between cultured 
HDF senescence and in vivo cellular senescence.  For 
example, cultured HDFs are exposed to chronic levels 
of damaging stimuli such as supraphysiologic oxygen 
and overabundant growth factors, possibly triggering a 
persistent stress response that could elevate TTP levels 
and lower HuR, AUF1, and TIA-1 levels.  Conversely, 
a more physiologic setting would cause stress condi-
tions of different type and magnitude in live organs, 
possibly impacting on TTR-RBP abundance.  While 
further experiments are needed to discern among these 
possibilities, our findings lead us to join many other 
laboratories in questioning the extent to which 
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human tissues has not yet been performed.  To carry out 
such an analysis, we obtained tissue arrays that 
contained a wide range of human tissue biopsies from 
different aged subjects (Methods);  in them, we studied 
TTR-RBP levels using an immunohistochemical analy-
sis method of color deconvolution that was recently 
adapted to tissue array analysis [52, 55].  Our 
examination of HuR, AUF1, TIA-1, and TTP 
expression by immunohistochemistry showed that these 
proteins were expressed ubiquitously and in high 
abundance among many tissues across age groups 
(Tables 1-4).  Lu and Schneider [53] examined 
systematically the expression of several TTR-RBPs in 
adult mice.  They reported that HuR was expressed in 
numerous tissues, including intestine, thymus, spleen, 
and liver, while it was almost undetectable in brain, 
heart, lung, kidney, and skeletal muscle [53].  This 
tissue distribution is in agreement with our findings 
(Table 1, Figure 2), although in some human tissues, 
such as liver and lung, a moderate percentage of cells 
also expressed HuR, in some cases with high intensities.  
The same authors showed that mouse AUF1 was 
expressed in highest abundance in thymus and spleen, 
but was also detectable in brain, testis, ovary, and 
uterus, intestine, and lung.  Although the levels of 
AUF1 in adult brain (M, O) could not be examined, the 
tissue distribution of AUF1 in mouse agrees largely 
with that seen in human.  Lu and Schneider used 
Western blot analysis to visualize AUF1, which allowed 
them to examine tissue-specific differences in isoform 
abundance [53].  This assessment was not possible on 
tissue arrays, since isoform-specific antibodies for 
immunohistochemistry are not yet available.  However, 
our analysis yielded other valuable information, such as 
the predominantly nuclear localization of AUF1 and its 
localization in specific cell types within a given organ 
(Figures 2-5 and data not shown). 
 
By employing western blot analysis, Beck and co-
workers [56] showed that TIA-1 mRNA and protein 
were expressed in mouse brain, spleen, and testis, but 
not in heart, lung, liver, skeletal muscle, or kidney.  Our 
results indicate that human TIA-1 was expressed in a 
more ample range of tissues, as we also detected high 
percentages of TIA-1-positive cells in the GI, urinary, 
and endocrine systems, and we found generally elevated 
TIA-1 signals among the different age groups (Table 3).  
The levels of TTP have also been examined in adult 
mouse, with high levels of TTP protein expressed in the 
liver, testis, and ovaries, as well as in macrophages [53, 
57].  In human tissues, we also detect TTP in these 
organs, but again find a broader tissue distribution for 
TTP, with high percentages of cells expressing TTP and 
high TTP signals in the urinary and muscular systems, 
and especially in the GI tract (Table 4, Figure 5). 
 
HuR has been implicated in numerous cell functions.   
Among the four TTR-RBPs studied, HuR is most 
tightly linked with proliferation.  Binding of HuR to 
mRNAs encoding cyclin A, cyclin B1, and c-fos led to 
their stabilization and/or increased translation, in turn 
accelerating cell division [49, 58, 59].  In keeping with 
this function, HuR was low in senescent HDFs (Figure 
1) and contributed to their terminally arrested 
phenotype [49].  Given this evidence, the finding that 
HuR was highly expressed in many adult tissues (M, O) 
was unexpected.  HuR could contribute to the division 
of epithelial cells from the GI tract, but it likely does not 
exert this function in many other tissues, such as the 
lung, reproductive organs, and urinary system, which 
are populated by many non-dividing cells.  Besides 
proliferation, HuR was shown to have a broad pro-
survival function, by binding to mRNAs encoding anti-
apoptotic proteins like prothymosin α, sirtuin 1 
(SIRT1), and bcl-2, and enhancing their expression [17, 
60, 61].  Additionally, HuR’s promotion of angiogene-
sis has been linked to its positive influence on the 
expression of HIF-1α and VEGF [62, 63].  Perhaps the 
elevated abundance of HuR in post-mitotic cells helps 
to carry out an anti-apoptotic function and to ensure 
sufficient oxygen supply in terminally differentiated 
tissues. 
 
All four TTR-RBPs have been linked to the immune 
response.  HuR function increased following mouse and 
human activation of macrophages and T cells [64-67].  
In turn, HuR stabilized and/or modulated the translation 
of target mRNAs encoding numerous cytokines, such as 
TNF-α, IL-6, IL-13, interferon γ, and GM-CSF.  AUF1 
also targets many of the same cytokine mRNAs, but it 
additionally downregulates IL-1β and IL-10 in immune 
cells [68-71].  Moreover, as AUF1-knockout mice were 
unable to degrade mRNAs encoding proinflammatory 
cytokines such as TNF-α and IL-1β, LPS treatment led 
to severe endotoxic shock [68].  TIA-1 also limits 
inflammation, at least in part by binding to the TNF-α 
mRNA and inhibiting TNF-α translation.  Thus, TNF-α 
was more highly expressed in macrophages isolated 
from TIA-1 knock-out mice than in those isolated from 
wild type mice [72].  Likewise, TTP limits inflamma-
tion by reducing the stability of GM-CSF, IL-2, and IL-
3 mRNAs [44, 73, 74].  Therefore, TTP-/- mice develop 
severe autoimmune dysfunction, myeloid hyperplasia, 
and inflammatory arthritis, due to deregulated TNF-α 
and GM-CSF levels [57].  In human immune organs, we 
observed a strong constitutive presence of HuR, AUF1, 
and TIA-1 across the age groups studied,  while  TTP  
 
 
www.impactaging.com                   692                                        AGING, August 2009, Vol.1 No.8abundance declined with increasing age.  While samples 
from the oldest donor group were unavailable on this 
panel of tissues, our findings suggest that multiple TTR-
RBPs likely contribute to maintaining the delicate 
balance that exists between promoting and inhibiting 
cytokine production.  Taken together, we propose that 
these TTR-RBPs help to maintain immune homeostasis 
throughout human life.  
 
In closing, cancer is among the most prominent age-
related diseases, and there is increasing recognition that 
TTR-RBPs can modulate oncogenesis [75, 76].  The 
pro-malignant influence of HuR and AUF1 is well 
established, and numerous cancer-related mRNA targets 
for these TTR-RBPs have been identified [15, 28].   
While TIA-1 can suppress the expression of cancer-
related genes such as COX-2 [36], TIA-1’s involvement 
in cancer is less well understood.  Interestingly, 
suppression of TTP expression in many cancer types 
correlated closely with the tumorigenic phenotype and 
with patient prognosis [77], suggesting that TTP could 
have tumor suppressor function.  In light of our findings 
that HuR and AUF1 are elevated while TTP levels 
decline in tissues from aged donors, we postulate that 
the higher HuR and AUF1 and lower TTP could 
contribute to the increased incidence of cancer seen 
with advancing age.     
 
While the links between senescence and aging remain to 
be clarified, this analysis reveals interesting distribution 
patterns for TTR-RBPs across tissues and age groups.  
Questions for future consideration include the influence 
of tissue type and donor age on the subcellular 
localization of TTR-RBPs and their post-translational 
modification, as these two parameters profoundly 
influence the metabolism of target mRNAs.  As we 
work towards addressing these queries, our findings 
provide a framework to study the possible involvement 
of TTR-RBPs in age-related processes, including the 
loss of physiologic function and the onset of diseases 




Cell culture and treatment.  WI-38 human diploid 
fibroblasts (Coriell Cell Repositories) were maintained 
in Dulbecco's modified Eagle medium (DMEM) 
(Invitrogen) supplemented with 10% (vol/vol) bovine 
calf serum (HyClone), 50 µg/ml streptomycin and 
penicillin, 0.1 mM nonessential amino acids, and 40 µM 
glutamine in a 5% CO2 incubator.  
 
Western blot analysis.  Whole-cell extracts were 
prepared as described previously [61].  Proteins were 
resolved by 12% sodium dodecyl sulfate (SDS)-poly-
acrylamide gel electrophoresis and transferred onto 
polyvinylidene difluoride membranes.  Monoclonal 
antibodies recognizing HuR (3A2; sc-5261) and GAPDH 
(6C5; sc-32233) as well as polyclonal antibodies 
recognizing TIA-1 (C-20; sc-1751) were from Santa Cruz 
Biotechnology; polyclonal antibodies recognizing AUF1 
(ab61193) or TTP (ab33058) were from Abcam. After 
secondary-antibody incubations, signals were detected by 
enhanced chemiluminescence (Amersham). 
 
Immunohistochemistry. Immunohistochemistry was 
performed with human adult and fetal normal tissue 
(Array II, BioChain Institute, Inc., Hayward, CA, and 
Pantomics, Inc., San Francisco, CA). The array slides 
were subjected to heat-induced epitope retrieval, 
incubation with primary antibody, and detection with 
the LSAB+ system (Dako, Carpinteria, CA, USA).  A 
monoclonal anti-HuR antibody (Molecular Probes Inc., 
Eugene, OR, USA) was used at 0.2 μg/ml.  A 
polyclonal anti-AUF1 antibody (Abcam) was used at 
1:2000 dilution, a polyclonal anti-TIA1 antibody (Santa 
Cruz) was used at 1:200 dilution, and a polyclonal anti-
TTP antibody (Abcam) was used at 1:1000 dilution. 
 
Slide scanning and image analysis of tissue arrays. 
Stained tissue sections were imaged at ×200 total 
magnification using a ScanScope CS system (Aperio, 
Vista, CA).  Whole-slide images were segmented into 
individual, 24-bit color core image files (TIFF) using 
TMALab software (Aperio) for further analysis.  Using 
ImageJ-based macros, regions of interest (ROI) were 
selected for each tissue microarray spot to exclude 
folded tissues and inappropriate tissue regions [52].  For 
example, for gastrointestinal tissues, only the epithelial 
cell layer was selected as the ROI, while muscular 
layers were excluded.  Color deconvolution was then 
used to separate the dye contribution at each pixel in a 
given image’s ROI; a count of all pixels above an 
arbitrary threshold was determined in order to exlude 
background staining and to establish a mean threshold 
of staining.  These values were used to generate the 
intensity value and to calculate the “% positivity” by 
dividing the total ROI pixel count by the DAB positive 
pixel count in the ROI. The values were further 
classified according to age:  fetal (F), young (Y, birth to 
30 yr-old), middle-aged (M, 30- to 60 yr-old), or old (O, 
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Tissue   Fetal  Adult    
Adrenal Gland   16y (M)  37y (F)  61y (F)    
Bladder   28w (F)  21y (F)  28y (M)  45y (M)   51y (F)  
  Bone Marrow   16y (M)   
Eye   1h (F)  72y (F)    
Breast   37y (F)  37y (F)  48y (F)    
Cerebellum   37w (F)  3m (M)  3y (M)  26y (M)   45y (M)  
Cerebral Cortex   37w (F)  3m (M)  3y (M)  16y (M)   26y (M)  
Fallopian Tube   22y (F)  22y (F)  30y (F)    
Esophagus   49y (M)  51y (M)  65y (M)    
Stomach   22w (M)  6y (M)  24y (M)  47y (M)   51y (M)  
Small Intestine   22w (F)  37y (M)  55y (M)  64y (M)   70y (M)  
Colon   37w (F)  8y (M)  24y (M)  36y (M)   85y (F)  
Rectum   56y (M)  56y (M)  70y (M)    
Heart   16w (F)  1h (F)  16y (M)  46y (M)   59y (M)  
Kidney   20w (F)  30y (M)  62y (F)  67y (M)   77y (M)  
Liver   12w (M)  30y (M)  43y (M)  56y (M)   80y (F)  
Lung   22w (F)  24y (M)  60y (M)  67y (M)   69y (M)  
Ovary   23y (F)  41y (F)  50y (F)    
Pancreas   16y (M)  46y (M)  49y (F)    
Parathyroid   37y (M)    
Pituitary Gland   54y (M)  55y (M)    
Prostate   72y (M)  74y (M)  75y (M)    
Skin   28w (F)  61y (F)  62y (F)  83y (F)    
Spinal Cord   1h (F)  46y (M)    
Spleen   26w (M)  12y (M)  24y (M)  49y (M)    
Striated Muscle   28w (F)  16y (M)  24y (M)  46y (M)   62y (F)  
Testis   16y (M)  69y (M)  73y (M)    
Thymus   29w (M)  1y (M)  2.5y (F)  13y (M)   24y (M)  
Thyroid   16y (M)  37y (M)  60y (F)    
Tongue   20w (M)  26y (M)    
Tonsil   9y (F)  10y (M)  13y (M)    
Ureter   2y (F)  30y (M)  46y (M)    
Uterus-Cervix   29y (F)  41y (F)  44y (F)    
Uterus-Endometrium   38y (F)  40y (F)  47y (F)    
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